Related Experiment Video
Updated: May 4, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target
Thomas F Lüscher1, Ulf Landmesser, Arnold von Eckardstein
1From Department of Cardiology, University Heart Center (T.F.L., U.L.), and Department of Clinical Chemistry (A.v.E.), University Hospital Zurich, Zurich, Switzerland; Division of Cardiovascular Research, Institute of Physiology, University of Zurich, Zurich, Switzerland (T.F.L., U.L.); and Department of Medicine, University of California, Los Angeles, CA (A.M.F.).
High-density lipoprotein (HDL) shows promise as a therapeutic target, but HDL cholesterol-raising drugs
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Proteomics
Background:
- High-density lipoprotein (HDL) is a complex lipoprotein with potential therapeutic applications.
- Epidemiological data and in vitro studies support HDL's role in cardiovascular health.
- Uncertainty remains regarding the clinical efficacy of HDL cholesterol-raising drugs.
Purpose of the Study:
- To investigate the impact of oxidative processes on HDL composition and function in cardiovascular disease.
- To explore the concept of HDL proteome remodeling in coronary artery disease (CAD) and acute coronary syndrome (ACS).
Main Methods:
- Analysis of HDL proteome composition in patients with CAD or ACS.
- Investigation of oxidative modification processes affecting HDL.
- Assessment of HDL function in relation to proteomic alterations.
Main Results:
- Recent studies indicate HDL modification in CAD and ACS patients due to oxidative stress.
- Oxidative processes lead to alterations in HDL's proteome composition (proteome remodeling).
- Modified HDL exhibits dysfunction, potentially impacting cardiovascular outcomes.
Conclusions:
- HDL dysfunction, driven by oxidative modification and proteome remodeling, is observed in cardiovascular disease.
- The effectiveness of HDL cholesterol-raising drugs may be limited by HDL modification.
- Further research is needed to understand and target HDL dysfunction in cardiovascular disease.
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures

